...According to The Guardian, the influx of these fake drugs from Asia, and especially China, is leading to a health crisis in some African countries, with the treatment of malaria being particularly at risk.
It’s hard to estimate exactly how widespread it is, but a recent study by the Fogarty Institute found that around a third of malaria drugs available in Uganda and Tanzania were falsified, susbstandard or degraded. Most of these were believed to originate in China, with a smaller number coming from India.
Specifically, here’s what the Fogarty researchers found:
Multicountry surveys from seven Southeast Asian countries included data on 1,437 samples of malaria drugs. About one third failed chemical analysis, nearly half were not correctly packaged and 36 percent were fakes. Similar surveys from 21 countries in sub-Saharan Africa provided data on 2,634 malaria drug samples. Of these, more than one third failed on the basis of chemical analysis and about 20 percent were found to be fakes. Only Burkina Faso provided data on packaging analysis, with about a 35 percent failure rate.